Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
admission, alfa, allele, bilateral, convened, erythrocyte, etavopivat, fault, Forma, highest, IRA, karyotype, mutation, Nordisk, Novo, onset, PKR, pneumonia, prejudice, preliminarily, pulmonary, Purported, pyruvate, resolution, ring, RS, scenario, sideroblast, TI, VAF, wrongdoing, zinpentraxin
Removed:
administered, AstraZeneca, begin, Constellation, infusion, modernizing, preclinical, Promedior, Sierra
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view